Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.39 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA4 | P22748 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9474747 | 1.00 | HCAR2 (0.39) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL4195192 | 0.94 | TAAR1 (0.44) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL471180 | 0.94 | TAAR1 (0.44) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL2787551 | 0.92 | TAAR1 (0.43) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL4190776 | 0.92 | TAAR1 (0.43) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7353784 | 0.92 | TAAR1 (0.43) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7353792 | 0.92 | TAAR1 (0.43) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7353777 | 0.92 | TAAR1 (0.43) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL9578841 | 0.87 | TAAR1 (0.40) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL10378479 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4042648-A | Olefin-acrylic ester copolymer-thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-08-16 | — | — | US | claimed |
| US-4001159-A | Aqueous dispersion of olefin-acrylate copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-01-04 | — | — | US | claimed |
| US-4000958-A | Method for treating leather | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-01-04 | — | — | US | claimed |
| US-3957732-A | ALTERNATING COPOLYMERS HAVING FUNCTIONAL GROUP AND PROCESS FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-05-18 | — | — | US | claimed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-20090092975-A1 | SELECTABLE MARKER | MOLOGIC LTD (GB) | 2009-04-09 | — | — | US | disclosed |
| US-20030013830-A1 | Reacting a thiosulfate salt with a halogenated styrenic monomer to form a styrenic thiosulfate salt monomer and then polymerization of said monomer in the presence of an initiator | BLEVINS RICHARD W (US) | 2003-01-16 | — | — | US | disclosed |
| US-6420505-B1 | STYRENE THIOSULFATE AND OLEFIN MONOMER | EASTMAN KODAK COMPANY | 2002-07-16 | — | — | US | disclosed |
| WO-1993013062-A1 | HALOGENATED TETRAENYL PROSTAGLANDIN DERIVATIVES | G.D. SEARLE & CO. (US) | 1993-07-08 | — | — | WO | disclosed |
| US-5177251-A | Cytoprotective, antisecretory, side effect reduction | G. D. SEARLE & CO. (US) | 1993-01-05 | — | — | US | disclosed |
| EP-0164270-A2 | Photo-polymerizable compositon and printing plate prepared therefrom | NAPP SYSTEMS INC. (US) | 1985-12-11 | — | — | EP | disclosed |
| US-4042648-A | Olefin-acrylic ester copolymer-thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-08-16 | — | — | US | disclosed |
| US-4001159-A | Aqueous dispersion of olefin-acrylate copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-01-04 | — | — | US | disclosed |
| US-4000958-A | Method for treating leather | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-01-04 | — | — | US | disclosed |
| US-3957732-A | ALTERNATING COPOLYMERS HAVING FUNCTIONAL GROUP AND PROCESS FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090092975-A1 | SELECTABLE MARKER | AMD1, PADI1, PSAT1 | HCAR2 826/4885HDAC3 3610/4885HDAC4 2929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.